STH

Across TCGA pan-cancer cohorts, STH Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated STH data layer compared with 18 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher STH Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated STH expression acts as an unfavorable survival marker.

HNSC, COAD, and READ are the cancer types where STH Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.132	0.687	<.001	48	view →
COAD	OS	Median	All	0.155	0.809	<.001	24	view →
READ	DFS	Median	All	0.336	0.843	.023	21	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

STH–HNSC (OS)

Open the HNSC breakdown →